CRN's latest "Life...supplemented" online promotion
This article was originally published in The Tan Sheet
Executive Summary
The Council for Responsible Nutrition's consumer wellness campaign, "Life...supplemented," announces its latest online promotion, the Year of Wellness Video Contest, in an April 21 release. The latest promotion of Life...supplemented, which focuses on three pillars of health, including healthy diet, vitamins and other supplements and regular exercise, offers Americans a chance to win $10,000 in "cash and prizes toward their own 'year of wellness.'" CRN will accept video entries via the campaign's Web site through May 17. Contestants should explain what they would do with $5,000 to improve their wellness. "Entries will be judged on clarity of expression, relevance to topic and creativity/originality," the trade group says. The $10,000 grand prize winner will receive $5,000 cash, a year's supply of supplements and consultations with a dietitian, life coach and personal trainer
You may also be interested in...
CRN campaign wins award
The "Life...supplemented" consumer wellness initiative, managed by the Council for Responsible Nutrition's CRN Foundation, won a Silver Anvil Award during the Public Relations Society of America's Silver Anvil Award ceremony in New York June 3. The campaign, which focuses on three pillars of health - healthy diet, dietary supplements and exercise - won for the category Reputation/Brand Management (Associations). The campaign is "an extraordinary effort by an industry that is passionate about its consumers and eager to educate the public about the valuable role dietary supplements play as part of a comprehensive approach to wellness," said CRN Senior VP of Communications Judy Blatman. "Life...supplemented" won several other awards, including the "Big Apple Award" from the Public Relations Society of America, New York Chapter. The latest "Life...supplemented" promotion was the Year of Wellness Video Contest, offering $10,000 in cash prizes (1"The Tan Sheet" April 26, 2010)
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.